Resting heart rate and risk of type 2 diabetes: A prospective cohort study and meta-analysis

Show simple item record

dc.contributor Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.author LEE, Dong Hoon
REZENDE, Leandro Fornias Machado de FMUSP-HC
HU, Frank B.
JEON, Justin Y.
GIOVANNUCCI, Edward L.
dc.date.issued 2019
dc.identifier.citation DIABETES-METABOLISM RESEARCH AND REVIEWS, v.35, n.2, article ID e3095, 9p, 2019
dc.identifier.issn 1520-7560
dc.identifier.uri http://observatorio.fm.usp.br/handle/OPI/31220
dc.description.abstract Background Positive association between resting heart rate (RHR) and risk of type 2 diabetes (T2D) has been documented in several studies. However, whether RHR is an independent predictor of T2D and its potential interaction with other risk factors of T2D remain unclear. Methods We conducted a prospective cohort study of 31 156 men from the Health Professionals Follow-up Study (1992-2012). Cox proportional hazard model was used to examine the association between RHR and T2D risk. We further examined whether this association is modified by known risk factors. Lastly, we conducted a meta-analysis of prospective cohort studies. Results During 505 380 person-years of follow-up, we identified 2338 incident T2D cases. The multivariable-adjusted hazard ratio (HR) comparing the highest vs lowest categories of RHR was 1.69 (95% confidence interval [CI], 1.43-2.01). Increase in 10 bpm of RHR was associated with 19% increased risk of T2D in the fully adjusted model (HR, 1.19; 95% CI, 1.14-1.24). The HRs of T2D associated with RHR were stronger among those with normal weight or without hypertension (P interaction < 0.001). Moreover, RHR with other known risk factors cumulatively increased T2D risk. A meta-analysis consistently showed a positive association between RHR and T2D risk (the summary relative risk [RR] for highest vs lowest RHR, 1.53; 95% CI, 1.26-1.86, n = 12, the summary RR per 10 bpm increase, 1.17; 95% CI, 1.09-1.26, n = 13). Conclusions High RHR was independently associated with increased risk of T2D. Our findings suggest that RHR, with other known risk factors, could be a useful tool to predict T2D risk.
dc.description.sponsorship · National Institutes of Health [UM1 CA167552, R01 HL35464]
· Sao Paulo Research Foundation (FAPESP) [2014/25614-4, 2016/21390-0]
dc.language.iso eng
dc.publisher WILEY
dc.relation.ispartof Diabetes-Metabolism Research and Reviews
dc.rights restrictedAccess
dc.subject interaction; meta-analysis; prospective cohort; resting heart rate; risk factor; type 2 diabetes
dc.subject.other nervous-system function; all-cause mortality; physical-fitness; life-style; men; classification; intervention; determinants; population; diagnosis
dc.title Resting heart rate and risk of type 2 diabetes: A prospective cohort study and meta-analysis
dc.type article
dc.rights.holder Copyright WILEY
dc.description.group LIM/38
dc.identifier.doi 10.1002/dmrr.3095
dc.identifier.pmid 30378246
dc.type.category original article
dc.type.version publishedVersion
hcfmusp.author REZENDE, Leandro Fornias Machado de:FM:
hcfmusp.author.external · LEE, Dong Hoon:Harvard TH Chan Sch Publ Hlth, Dept Nutr, 665 Huntington Ave,Bldg 2,3rd Floor, Boston, MA 02115 USA
· HU, Frank B.:Harvard TH Chan Sch Publ Hlth, Dept Nutr, 665 Huntington Ave,Bldg 2,3rd Floor, Boston, MA 02115 USA; Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; Harvard Med Sch, Boston, MA USA
· JEON, Justin Y.:Yonsei Univ, Dept Sport Ind Studies, Exercise Med & Rehabil Lab, Seoul, South Korea; Yonsei Univ, Coll Med, ICONS, Exercise Med Ctr Diabet & Canc Patients, Seoul, South Korea
· GIOVANNUCCI, Edward L.:Harvard TH Chan Sch Publ Hlth, Dept Nutr, 665 Huntington Ave,Bldg 2,3rd Floor, Boston, MA 02115 USA; Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; Harvard Med Sch, Boston, MA USA
hcfmusp.origem.id WOS:000457591100009
hcfmusp.origem.id 2-s2.0-85056769553
hcfmusp.publisher.city HOBOKEN
hcfmusp.publisher.country USA
hcfmusp.relation.reference · Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011
· [Anonymous], 2017, NAT DIAB STAT REP
· Ardisson Korat Andres V, 2014, Curr Nutr Rep, V3, P345
· Aune D, 2015, NUTR METAB CARDIOVAS, V25, P526, DOI 10.1016/j.numecd.2015.02.008
· Aune D, 2017, NUTR METABOLISM CARD
· BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395
· Bohm M, 2015, AM J MED, V128, P219, DOI 10.1016/j.amjmed.2014.09.016
· Carnethon MR, 2008, DIABETES CARE, V31, P335, DOI 10.2337/dc07-0874
· Carnethon MR, 2006, DIABETES CARE, V29, P914, DOI 10.2337/diacare.29.04.06.dc05-1729
· Carnethon MR, 2003, CIRCULATION, V107, P2190, DOI 10.1161/01.CIR.0000066324.74807.95
· FESKENS EJM, 1989, AM J EPIDEMIOL, V130, P1101, DOI 10.1093/oxfordjournals.aje.a115437
· Fox K, 2008, LANCET, V372, P817, DOI 10.1016/S0140-6736(08)61171-X
· Gavin JR, 1997, DIABETES CARE, V20, P1183
· Grantham NM, 2013, DIABETIC MED, V30, P421, DOI 10.1111/dme.12045
· HARRIS M, 1979, DIABETES, V28, P1039
· Jae SY, 2016, AM J MED, V129, DOI 10.1016/j.amjmed.2016.01.014
· Jensen MT, 2013, HEART, V99, P882, DOI 10.1136/heartjnl-2012-303375
· Julius S, 1992, Blood Press, V1, P9, DOI 10.3109/08037059209065119
· Kima'b G, 2017, DIABETES METAB, V43, P25, DOI 10.1016/j.diabet.2016.09.002
· Knowler WC, 2002, NEW ENGL J MED, V346, P393
· Lahiri MK, 2008, J AM COLL CARDIOL, V51, P1725, DOI 10.1016/j.jacc.2008.01.038
· Lee DH, 2016, BREAST CANCER RES TR, V159, P375, DOI 10.1007/s10549-016-3938-1
· Lee MK, 2018, CLIN CHIMICA ACTA
· Mathur MBDP, 2018, EPIDEMIOLOGY
· Nagaya T, 2010, INT J EPIDEMIOL, V39, P215, DOI 10.1093/ije/dyp229
· Palatini P, 2006, DRUGS, V66, P133, DOI 10.2165/00003495-200666020-00001
· Palatini P, 1999, AM J HYPERTENS, V12, p3S, DOI 10.1016/S0895-7061(98)00207-6
· Park J, 1932, RESTING HEART RATE I
· Perin PC, 2001, CLIN EXP HYPERTENS, V23, P45, DOI 10.1081/CEH-100001196
· PERRY IJ, 1995, BRIT MED J, V310, P560, DOI 10.1136/bmj.310.6979.560
· Rogowski O, 2007, HEART, V93, P940, DOI 10.1136/hrt.2006.101949
· Sajadieh A, 2004, EUR HEART J, V25, P363, DOI 10.1016/j.ehj.2003.12.003
· SANDVIK L, 1993, NEW ENGL J MED, V328, P533, DOI 10.1056/NEJM199302253280803
· Shigetoh Y, 2009, AM J HYPERTENS, V22, P151, DOI 10.1038/ajh.2008.331
· Szklo M, 2014, EPIDEMIOLOGY BASICS
· VanderWeele TJ, 2017, ANN INTERN MED, V167, P268, DOI 10.7326/M16-2607
· Wang HD, 2017, LANCET, V390, P1084, DOI 10.1016/S0140-6736(17)31833-0
· Wang L, 2015, INT J EPIDEMIOL, V44, P689, DOI 10.1093/ije/dyv079
· World Health Organization, 2016, GLOB REP DIAB
· Yamaguchi J, 2005, AM J HYPERTENS, V18, P1218, DOI 10.1016/j.amjhyper.2005.04.009
· Yang HI, 1873, ASS RESTING HEART RA
· Zhang J, 1999, EUR HEART J, V20, P103, DOI 10.1053/euhj.1999.1230
· Zhang SY, 2016, SCI REP-UK, V6, DOI 10.1038/srep23939
· Zhang XL, 2010, INT J EPIDEMIOL, V39, P900, DOI 10.1093/ije/dyq068
dc.description.index MEDLINE
hcfmusp.citation.scopus 1
hcfmusp.citation.wos 0
hcfmusp.affiliation.country Brasil
hcfmusp.affiliation.country Coréia do Sul
hcfmusp.affiliation.country Estados Unidos


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace



Browse

My Account

Statistics